Satu Mustjoki

14.9k total citations
212 papers, 5.5k citations indexed

About

Satu Mustjoki is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Satu Mustjoki has authored 212 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Hematology, 101 papers in Genetics and 84 papers in Immunology. Recurrent topics in Satu Mustjoki's work include Chronic Lymphocytic Leukemia Research (96 papers), Chronic Myeloid Leukemia Treatments (91 papers) and Immune Cell Function and Interaction (49 papers). Satu Mustjoki is often cited by papers focused on Chronic Lymphocytic Leukemia Research (96 papers), Chronic Myeloid Leukemia Treatments (91 papers) and Immune Cell Function and Interaction (49 papers). Satu Mustjoki collaborates with scholars based in Finland, Sweden and United States. Satu Mustjoki's co-authors include Kimmo Porkka, Riitta Alitalo, Oscar Brück, Anna Kreutzman, Hanna Rajala, Kari Alitalo, Shahin Rafii, Petri Salvén, Leif Stenke and Ulla Olsson‐Strömberg and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Satu Mustjoki

199 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satu Mustjoki Finland	42	2.2k	2.0k	1.9k	1.8k	1.5k	212	5.5k
Katherine R. Calvo United States	39	2.4k 1.1×	1.4k 0.7×	1.3k 0.7×	843 0.5×	1.7k 1.1×	141	5.1k
Marc Loriaux United States	34	2.2k 1.0×	2.1k 1.1×	678 0.4×	808 0.5×	2.0k 1.3×	98	4.5k
Júlia Almeida Spain	42	1.5k 0.7×	1.4k 0.7×	2.3k 1.2×	1.0k 0.6×	1.2k 0.8×	132	4.9k
Valter Gattei Italy	43	876 0.4×	2.5k 1.3×	2.1k 1.1×	1.4k 0.8×	1.7k 1.1×	222	5.7k
R. Coleman Lindsley United States	27	3.0k 1.3×	1.5k 0.8×	1.8k 0.9×	685 0.4×	2.0k 1.3×	76	5.8k
Yasuhiro Oki United States	40	1.3k 0.6×	1.7k 0.9×	1.0k 0.5×	2.3k 1.3×	2.2k 1.4×	207	6.3k
Thierry Rème France	43	2.0k 0.9×	545 0.3×	1.8k 0.9×	1.4k 0.8×	2.5k 1.7×	102	5.4k
Frederic I. Preffer United States	43	1.6k 0.7×	748 0.4×	2.3k 1.2×	2.0k 1.2×	2.0k 1.3×	112	7.0k
Norma C. Gutiérrez Spain	41	3.4k 1.5×	1.2k 0.6×	645 0.3×	1.7k 1.0×	3.3k 2.2×	179	5.6k
Martine Amiot France	49	2.9k 1.3×	799 0.4×	1.8k 1.0×	2.7k 1.5×	4.8k 3.2×	131	7.9k

Countries citing papers authored by Satu Mustjoki

Since Specialization

Citations

This map shows the geographic impact of Satu Mustjoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satu Mustjoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satu Mustjoki more than expected).

Fields of papers citing papers by Satu Mustjoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satu Mustjoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satu Mustjoki. The network helps show where Satu Mustjoki may publish in the future.

Co-authorship network of co-authors of Satu Mustjoki

This figure shows the co-authorship network connecting the top 25 collaborators of Satu Mustjoki. A scholar is included among the top collaborators of Satu Mustjoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satu Mustjoki. Satu Mustjoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jokinen, Emmi, Essi Laajala, Shady Adnan Awad, et al.. (2025). High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia. Blood. 145(15). 1670–1686. 2 indexed citations

Jokinen, Emmi, Jani Huuhtanen, Jay Klievink, et al.. (2025). Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer. Leukemia. 39(11). 2767–2778.

Dollar, James J., Christina L. Decatur, Carlos Estévez, et al.. (2024). 154P Phase II study of nivolumab and relatlimab utilizing single cell analysis of circulating T cells reveals immune features associated with response to dual PD-1 and LAG-3 inhibition. Annals of Oncology. 35. S276–S277.

Dhapola, Parashar, Mikael N.E. Sommarin, Shamit Soneji, et al.. (2024). Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. eLife. 12. 3 indexed citations

Myllymäki, Mikko, Timo Järvinen, Mikko Keränen, et al.. (2024). Somatic mutations associate with clonal expansion of CD8 ⁺ T cells. Science Advances. 10(23). eadj0787–eadj0787. 1 indexed citations

Huuhtanen, Jani, Katriina Peltola, Tapio Lönnberg, et al.. (2023). Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma. Journal of Clinical Investigation. 133(6). 60 indexed citations

Dhapola, Parashar, Mikael N.E. Sommarin, Shamit Soneji, et al.. (2023). Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. eLife. 12. 3 indexed citations

Teramo, Antonella, Vanessa Rebecca Gasparini, Jani Huuhtanen, et al.. (2022). Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia. Blood Cancer Journal. 12(2). 31–31. 22 indexed citations

Brück, Oscar, Helena Hohtari, Aleksandr Ianevski, et al.. (2021). Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS. Blood Cancer Discovery. 2(3). 238–249. 36 indexed citations

10.

Chiaro, Jacopo, Thomas Whalley, Cristian Capasso, et al.. (2021). Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer Immunology Research. 9(8). 981–993. 25 indexed citations

11.

Leivonen, Suvi‐Katri, Oscar Brück, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2020). Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma. Cancers. 12(4). 877–877. 35 indexed citations

12.

Awad, Shady Adnan, Matti Kankainen, Teija Ojala, et al.. (2020). Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia. Blood Advances. 4(3). 546–559. 38 indexed citations

13.

Dufva, Olli, Pilvi Maliniemi, Aleksandr Ianevski, et al.. (2019). Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity. Blood. 135(9). 597–609. 157 indexed citations

14.

He, Liye, Jing Tang, Emma Andersson, et al.. (2018). Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients. Cancer Research. 78(9). 2407–2418. 55 indexed citations

15.

Kreutzman, Anna, Ana Marcos‐Jiménez, Mette Ilander, et al.. (2017). Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner. Clinical Cancer Research. 23(21). 6697–6707. 33 indexed citations

16.

Hekim, Can, Mette Ilander, Jun Yan, et al.. (2017). Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. Cancer Immunology Research. 5(2). 157–169. 37 indexed citations

17.

Thielen, Noortje, Johan Richter, Gisela Barbany, et al.. (2016). Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy. Clinical Cancer Research. 22(16). 4030–4038. 14 indexed citations

18.

Valori, Miko, Lilja Jansson, Kimmo Porkka, et al.. (2016). Lymphoid somatic mutations in multiple sclerosis. Multiple Sclerosis Journal. 22. 170–171. 2 indexed citations

19.

Christiansson, Lisa, Stina Söderlund, Sara M. Mangsbo, et al.. (2015). The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses. Molecular Cancer Therapeutics. 14(5). 1181–1191. 57 indexed citations

20.

Ilander, Mette, Anna Kreutzman, & Satu Mustjoki. (2014). IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia. OncoImmunology. 3(5). e28781–e28781. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact